Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239; NSC# 724772) for Patients with High Allelic Ratio FLT3/ITDCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
